Study guide

31.2 Conflict of Interest

FACHE Board of Governors Exam in Healthcare Management Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the FACHE Credential 1.2 Current Exam Facts 1.3 Eligibility, Application & Recertification

2 Healthcare Systems & Trends

2.1 Healthcare and Medical Terminology 2.2 Healthcare Trends 2.3 Continuum of Care Levels

3 Healthcare Organizations & Services

3.1 Levels of Service from a Business Perspective 3.2 Types of Healthcare Organizations 3.3 Ancillary and Support Services

4 Integration, Clinicians & Staff Perspectives

4.1 Integration, Competition & Partnerships 4.2 Clinician Roles and Qualifying Criteria 4.3 Staff Perspectives & Evidence-Based Management

5 Patient Perspective & Care Delivery

5.1 Patient vs Provider Perspective 5.2 Access, Quality, Cost & Community 5.3 Care Delivery Models and Access Points

6 Digital Health, Population Health & Prevention

6.1 Digital Health 6.2 Population Health Concepts 6.3 Social Determinants & Preventative Medicine

7 Management Planning & Organizational Systems

7.1 Implementation Planning 7.2 Emergency Preparedness & NIMS 7.3 Organizational Systems & Management Functions

8 Leadership, Teams & Change

8.1 Leadership and Communication Styles 8.2 Team-Building Techniques 8.3 Change Management & Organizational Development

9 Collaboration, DEIJ & Networks

9.1 Stakeholder Collaboration 9.2 DEIJ & Resource Allocation 9.3 Network Structures & Collective Bargaining

10 Financial Accounting & Budgeting

10.1 Financial Accounting and Ratios 10.2 Operating Budgets 10.3 Capital Budgeting

11 Reimbursement, Productivity & Controls

11.1 Reimbursement Methodologies 11.2 Productivity Measures 11.3 Financial Controls

12 Revenue, Business Cases & Capital Finance

12.1 Revenue Generation and Payer Mix 12.2 Business Cases & Financial Decision Impacts 12.3 Asset Management & Financing

13 Philanthropy, Supply Chain & Revenue Cycle

13.1 Philanthropy and Foundations 13.2 Supply Chain Management 13.3 Revenue Cycle

14 HR Laws, Recruitment & Staffing

14.1 HR Laws and Regulations 14.2 Recruitment and Retention 14.3 Staffing Methodologies

15 Performance, Engagement & Compensation

15.1 Performance Management Systems 15.2 Motivation, Development & Engagement 15.3 Compensation and Benefits

16 Workplace Safety, Conflict & Labor Relations

16.1 Employee Safety, Security & Health 16.2 Conflict, Grievances & Selection 16.3 Labor Relations & HR Decision Impacts

17 Job Design, Succession & Coaching

17.1 Job Design 17.2 Succession Planning, Mentorship & Coaching

18 Confidentiality, Compliance & Payment Rules

18.1 Confidentiality and Privacy Laws 18.2 Healthcare Compliance Laws 18.3 Medicare, Medicaid & Third-Party Payment Regulations

19 Accreditation, Patient Rights & Ownership Rules

19.1 Accreditation & Inspection Standards 19.2 Patients' Rights Laws 19.3 Nonprofit vs For-Profit Requirements

20 Regulatory Impacts, Labor Law & M&A

20.1 Regulatory Impact on Executive Decisions 20.2 Collective Bargaining Laws 20.3 Legal Implications of Mergers & Acquisitions

21 Benchmarking, Peer Review & Risk

21.1 Benchmarking & Best Practices 21.2 Medical Staff Peer Review 21.3 Risk Management Programs

22 Improvement Methods & Measurement

22.1 PDSA, Lean & Six Sigma 22.2 Clinical Performance Improvement & Pathways 22.3 Quality Measurement & HCAHPS

23 Utilization, Patient Safety & Quality Impacts

23.1 Utilization Review & Case Management 23.2 Patient Safety Tools 23.3 How Quality Impacts Operations

24 Strategic Planning, Business Planning & Contracts

24.1 Strategic Planning Process 24.2 Business Planning for Services 24.3 Business Contracts

25 Socioeconomic Context, Marketing & Media

25.1 Socioeconomic Environment 25.2 Marketing Principles 25.3 Media, Social Media & Community Relations

26 Negotiation & Business Decision Impacts

26.1 Contract Negotiation 26.2 Business Decision Impacts

27 Health IT Operations, Trends & Regulation

27.1 IT in Business Operations 27.2 Technology Trends & Clinical Applications 27.3 HIPAA Security, HITECH & Interoperability

28 Informatics, IT Impacts & Continuity

28.1 Health Informatics for Operational Decisions 28.2 IT Decision Impacts 28.3 Information Systems Continuity

29 IT Acquisition & Analytics

29.1 IT Selection, Acquisition & Maintenance 29.2 Healthcare Analytics & Clinical Informatics

30 ACHE Ethics, Patient Rights & Ethics Committees

30.1 ACHE Code of Ethics 30.2 Patients' Rights & Responsibilities 30.3 Ethics Committees

31 Diversity, Conflicts of Interest & Research Ethics

31.1 Cultural & Spiritual Diversity 31.2 Conflict of Interest 31.3 Unethical Actions & Human-Subject Research

32 Professional Norms, Ethical Culture & Diversity Statement

32.1 Professional Norms & Standards 32.2 Creating an Ethical Culture 32.3 ACHE Statement on Diversity

33 Governance Theory, Structure & Medical Staff

33.1 Governance Theory 33.2 Governance Structure & Operations 33.3 Medical Staff Structure

34 Board Accountability & Public Policy

34.1 Board Role, Accountability & Fiduciary Duty 34.2 Public Policy & Advocacy

31.2 Conflict of Interest

Key Takeaways Explain This Topic AI

A conflict of interest (COI) exists when personal, financial, professional, or dual-role interests could improperly influence—or reasonably appear to influence—decisions owed to patients, the organization, or the public

ACHE-aligned executives disclose conflicts, recuse when required, avoid exploiting professional relationships for personal gain, and implement organizational COI principles with monitoring—not only private good intentions

Governance tools include bylaws, board/executive disclosure forms, gift and vendor policies, medical-staff financial relationship rules, research COI policies, and procurement integrity controls

Legal overlays (fraud and abuse laws, tax-exempt intermediate sanctions, securities/fiduciary duties, anti-kickback and Stark themes for referrals, False Claims Act risk from tainted arrangements) interact with ethics policy; “legal gray” is not automatic ethical clearance

FACHE scenarios favor transparency, recusal, documentation, and patient/organization-first choices over hidden dual roles, vendor favoritism, self-referral without safeguards, or silencing concerns about conflicts

Last updated: August 2026

Conflict of Interest

Quick Answer: A conflict of interest (COI) arises when a personal interest (financial, familial, professional, or dual-role) could compromise—or appear to compromise—loyalty to patients, the organization, or the public. Healthcare executives must identify, disclose, manage, and when necessary avoid conflicts through bylaws, board policy, gift rules, vendor integrity, and recusal. ACHE’s Code explicitly requires disclosure of financial and other conflicts and forbids exploiting professional relationships for personal gain.

Professionalism and Ethics items on COI (E5) test whether leaders protect trust . Healthcare decisions allocate scarce resources, influence referrals, award contracts, set compensation, and shape research. Hidden interests destroy legitimacy even when outcomes happen to be clinically acceptable.

Defining COI for Executives

COI is broader than criminal bribery. Categories executives must recognize:

Type Examples

Financial Equity in a vendor; consulting fees from a device firm; real-estate interest in a site the hospital may lease; spouse ownership of a competing ambulatory center

Familial / relational Nepotism in hiring or contracting; board member’s relative seeking exclusive privileges

Dual roles Employed executive sitting on a supplier board; medical director paid by a product company while selecting formulary or capital equipment

  • Gifts & hospitality Lavish dinners, travel, honoraria, or entertainment that create indebtedness
  • Referral / ownership Physician or executive ownership of entities that receive referrals from the organization
  • Research / academic Investigator financial ties to sponsors of trials conducted at the organization
  • Political / personal prestige Steering contracts to allies to advance a political career or private brand

Appearance of conflict matters. Even without proven corruption, reasonable observers may doubt fairness. Ethical systems manage appearance through transparency and structural safeguards.

ACHE and Organizational Ethics Framing

Under the ACHE Code, executives shall not exploit professional relationships for personal gain and shall disclose conflicts—subject to board or organizational review and avoidance when required. Organizational duties include implementing conflict-of-interest principles and monitoring compliance, alongside codes of ethics and whistleblower protections.

Practical translation:

Annual (and transactional) disclosure for board members, executives, key decision-makers, and often medical staff leaders

Review by a designated body (governance committee, compliance, board chair, or COI committee)

Management plans : recusal from discussion and vote; divestiture; restricted access to negotiations; independent valuation; second-signature procurement; public reporting where required

  • Documentation of the conflict, the plan, and compliance with the plan
  • Culture that treats disclosure as professional duty, not career suicide
  • Laws, Bylaws, and Policies—Layered Controls

Executives solve COI with a stack of instruments, not slogans:

Corporate bylaws and board policy typically require directors and officers to disclose interests in transactions, recuse from related votes, and authorize only fair transactions (often with independent approval and documented fairness for tax-exempt entities). Intermediate sanctions and private inurement risks make self-dealing especially dangerous for nonprofit hospitals.

Employment and executive contracts may include non-compete, outside-activity approval, and IP/assignment clauses that limit dual employment with competitors or vendors.

Gift, entertainment, and vendor interaction policies set thresholds (e.g., modest educational items only), ban cash equivalents, and restrict industry-funded travel that creates influence. Pharmaceutical and device relationships for employed physicians often sit under stricter medical-staff or corporate integrity policies.

Procurement and supply-chain policy requires competitive bidding or documented sole-source justification, conflict screening of evaluators, and separation of requester and approver roles.

Medical staff bylaws / financial relationship policies address ownership of ancillary services, consulting agreements, and disclosure of industry payments (including awareness of public reporting such as Open Payments data where relevant).

Research COI policies require investigators to disclose sponsor relationships; management may include independent monitoring, modified roles, or prohibition of certain roles in human-subjects research when financial stakes are significant.

Fraud and abuse overlay: arrangements that look like payment for referrals or that induce medically unnecessary utilization can violate federal anti-kickback, physician self-referral (Stark), and False Claims Act frameworks. Ethics and compliance should coordinate: an arrangement that is “disclosed” is not automatically legal, and a “legal opinion” does not erase ethical appearance problems if patients are not put first.

Solutions: Manage, Mitigate, or Avoid

Not every COI is forbidden; unmanaged COI is. A decision framework:

Avoid when the interest is severe, continuous, and cannot be structured without corrupting core duties (e.g., CEO equity in the sole bidder for a massive EHR contract with no independent process)

Mitigate with recusal, independent review, and transparency when the relationship is limited and value to the organization is clear

  • Disclose always when material—late disclosure after a deal closes is a red flag
  • Never hide behind “everyone networks this way” or “I would have chosen that vendor anyway”

Board and executive recusal must be real: leaving the room for discussion and vote, not merely abstaining after lobbying colleagues. Minutes should reflect the process.

Common Healthcare Scenarios

Vendor selection: COO’s sibling owns a construction firm bidding on expansion—disclose, recuse from evaluation, independent scoring, document fair process.

Philanthropy with strings: Donor wants naming rights tied to preferential clinical access—ethics and compliance review; care access cannot be sold.

Physician joint venture: Ownership of an ASC receiving hospital referrals—structure under legal safe harbors where available; ensure medical necessity and patient choice; disclose to patients as required; avoid pressure on employed physicians to refer for organizational profit alone.

Industry-funded education: Accept only if content control, disclosure, and CME standards protect independence.

Moonlighting / outside boards: Require approval; bar confidential information use; manage time conflicts.

Detection, Reporting, and Culture

COI programs fail without reporting pathways. Hotlines, non-retaliation, audit of high-risk contracts, and review of Open Payments or vendor spend outliers help. Leaders model behavior by disclosing their own interests promptly and by declining gifts that create indebtedness.

Punishing employees who flag executive conflicts is an ethics failure cascading into compliance risk. Boards must oversee executive COI independently; the CEO cannot be sole judge of the CEO’s conflicts.

  • Common Exam Traps
  • Treating COI as only criminal bribery, ignoring appearance and fiduciary duty
  • Disclosure without recusal or management plan
  • Using “patient benefit” rhetoric to justify self-dealing contracts
  • Allowing the conflicted person to chair the vendor selection committee
  • Confusing board fundraising relationships with automatic approval of related-party deals
  • Assuming for-profit systems have no COI duties (fiduciary and fraud rules still apply; ethics still apply)
  • Executive Decision Lens

Before a transaction, ask: Who benefits personally if this option wins? Have all material interests been disclosed to the right body? Would a reasonable patient or community member trust this process if fully public? Is recusal documented? Is there an independent fairness check? Does law counsel and compliance agree the structure is sound—and does ethics still support it? Conflict-of-interest management is how executives prove that professional power serves patients and mission first—the core of ACHE professionalism.